Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A mouse model in a petri dish on a lab bench, surrounded by glassware.

Aug 21, 2026

DANDELION Computational Tool Identifies Previously Unknown Asthma-Related Genes and Pathway

Researchers from the University of Chicago and Columbia University have developed a novel computational tool named DANDELION, which identifies genes most directly associated with asthma, significantly advancing the understanding of the disease's genetic underpinnings.The DANDELION tool leverages trans-gene regulation to pinpoint 21 asthma-related genes, many of which were previously unidentified. By utilizing CRISPR gene-editing and mouse models, the team validated that these genes contribute to
A reference slide on a lab bench in a pathology lab

Aug 21, 2026

Yorkshire tech designed to help AI in cancer diagnostics set for roll-out on global stage

A groundbreaking technology from Leeds Teaching Hospitals NHS Trust, known as TANGO, is poised for global implementation following a commercial partnership with Epredia, a leading diagnostic glass slide manufacturer.TANGO represents a significant advancement in pathology, facilitating the integration of digital pathology and AI into cancer diagnostics. Unlike traditional methods that rely on staining techniques, TANGO employs a unique reference slide designed to enhance quality control during th
A glass vial with a colorful drug compound on a lab bench

Aug 21, 2026

DeepCyte Launches Single-Cell Metabolomic Reference Atlas of Drug Toxicity Mechanisms

DeepCyte has introduced the DeeTox Atlas, a pioneering single-cell metabolomic reference designed to elucidate drug toxicity mechanisms. This initiative is set to engage in pilot programs with leading pharmaceutical firms in the near future.The DeeTox Atlas serves as a foundational dataset derived from two separate single-cell metabolomics studies, encompassing around 100 toxic compounds, 300,000 individual cells, and approximately 500 metabolites per cell. The data includes over 3,000 single-ce
Press release cover image

Aug 21, 2026

Press release

TransformativeMed Partners with Red Rover Health to Bring Agentic AI Across Clinical Workflows

Companies to showcase agentic discharge planning solution at Oracle Health SummitSEATTLE, Aug. 21, 2026 /PRNewswire/ -- TransformativeMed, a 'Best in Klas' Healthcare IT company, today announced a strategic partnership with Red Rover Health to design and deploy agentic AI solutions that work natively inside Oracle Health's EHR.Continue Reading The partnership combines TransformativeMed's Agentic Clinical Operating System (ACOS) – a platform that enables agentic AI directly into
Press release cover image

Aug 21, 2026

Press release

Coreline Soft and INFINITT North America Deploy Chest CT-Based AI Reading Workflow at St. Joseph's Health

PHILLIPSBURG, N.J. and ATLANTA, Aug. 21, 2026 /PRNewswire/ -- Coreline Soft, a leading medical AI innovator, and INFINITT North America have announced the deployment of a chest CT-based AI reading workflow at St. Joseph's Health in Paterson, New Jersey. This marks the second major North American collaboration between the two companies, following their successful implementation at ImageCare Radiology.The new workflow leverages Coreline Soft's AVIEW platform, integrating advanced AI analysis direc
Press release cover image

Aug 21, 2026

Press release

O'Shaughnessy Ventures Funds Research Into How Cells Heal

Wiktoria Pawlak receives an O'Shaughnessy Fellowship to build an AI model that decodes cells' electrical signals, enabling therapies that guide regeneration rather than relying on drugs.GREENWICH, Conn., Aug. 21, 2026 /PRNewswire/ -- O'Shaughnessy Ventures LLC (OSV), an investment firm that empowers creators, has awarded an O'Shaughnessy Fellowship to Wiktoria Pawlak, a bioengineer and AI researcher based in Poland.Continue Reading Pawlak will use the fellowship to build an AI m
Press release cover image

Aug 21, 2026

Press release

The9's Investee Nanyang Biologics (NYB) Advancing toward Nasdaq Listing after RFAI Cleared Vote at Shareholders Extraordinary General Meeting

Milestone Marks Further Progress in The9's Strategic Investment in AI-Driven Drug Discovery; The9 Expects to Hold Approximately 15% to 16% of the Combined, Nasdaq-Listed CompanySHANGHAI, Aug. 21, 2026 /PRNewswire/ -- The9 Limited (Nasdaq: NCTY) ("The9" or the "Company"), a global, diversified high-tech company, today announced that Nanyang Biologics Pte. Ltd. ("NYB"), a Singapore-based, AI-driven drug discovery company in which The9 holds a strategic equity stake, has taken a significant step to
A flat illustration of a tissue sample and genomic data strands in a minimalist style.

Aug 21, 2026

Bioptimus, Cancer Research Horizons partner on AI-powered precision medicine

Bioptimus, a Paris-based AI biotech firm, has partnered with Cancer Research Horizons to enhance AI-driven precision medicine through access to extensive colorectal cancer datasets.The collaboration grants Bioptimus access to the S:CORT dataset, which encompasses over 1,750 patient profiles and integrates multiple data modalities, including imaging and genomic information. This resource is part of Bioptimus's broader initiative, STELA, aimed at constructing a comprehensive multimodal tissue atla
Press release cover image

Aug 21, 2026

Press release

IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today announced that its AI-enabled Clinical Decision Support Tool, developed in collaboration with Breakthrough T1D, has won the 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year.Powered by IQVIA Healthcare-grade AI®, the tool tackles a long-standing problem
Press release cover image

Aug 21, 2026

Press release

FDA Clears C2N Diagnostics’ PrecivityAD2® — First Alzheimer’s Blood Test for Adults with Cognitive Symptoms as Young as 40

FDA Clearance Builds on C2N’s Legacy of Delivering Transformative Solutions to Address Alzheimer’s Disease CrisisPrecivityAD2® Becomes the First FDA-Cleared Test Powered by High Resolution Mass Spectrometry and Multiple Analyte Algorithm Score for Aiding in DiagnosisSingle Blood Test Delivers High Diagnostic Performance to Aid Health Care Professionals in Ruling-In and Ruling-Out Clinical Alzheimer’s Disease at its Earliest StagesST. LOUIS--(BUSINESS WIRE)--#Alzheimers--The U.S. Food & Drug
Chronotrack device on a bedside table next to a sleep diary in a cozy bedroom

Aug 21, 2026

Sleep AI startup Asleep expands into prescription market with second pharma deal

Asleep, an innovative AI startup specializing in sleep disorder diagnostics, is shifting its focus from wellness applications to the prescription market, establishing partnerships with major pharmaceutical companies.The company recently signed a distribution agreement with Handok for its digital medical device, Chronotrack, which automates the recording of sleep patterns. This follows a previous partnership with Chong Kun Dang for Apnotrack, a tool designed to diagnose sleep apnea. Chronotrack o
A minimalist representation of a health record document with a dollar sign, symbolizing funding in healthcare.

Aug 20, 2026

VA adds up to $17B to its federal EHR contract with Oracle

The U.S. Department of Veterans Affairs (VA) has significantly boosted its funding for the Electronic Health Record Modernization (EHRM) program, adding $17 billion to its contract with Oracle Health, which now totals up to $27 billion over a potential three-year extension.This substantial financial commitment aims to enhance the integration of patient health records across military and veteran healthcare systems, as well as for agencies like the U.S. Coast Guard and NOAA. The recent updates to